On Chemball
My Chemball
+86-571-8627 3270
Shandong Jincheng Pharmaceutical Group Co.,Ltd.
Shandong Jincheng Pharmaceutical Group Co.,Ltd.
20 YRS
Shandong, China
Main Products:
L-Glutathione Reduced / N,N'-Dicyclohexylcarbodiimide / 5-(Acetoacetamido)-2-Benzimidazolinone / Tetrahydro-2-Methyl-3-Thioxo-1,2,4-Triazine-5,6-Dione / Acetonitrile / Ethyl Acetoacetate / Tert-Butyl Acetoacetate / N,N'-Diisoprop Thiourea / Isopropyl Acetoacetate / Ethyl 2-Chloroacetoacetate / Ethyl 4-Chloroacetoacetate / 5-Nitro-2-Benzimidazolone / 3-Hydroxy-N-(2-Oxo-1,3-Dihydrobenzoimidazol-5-Yl)Naphthalene-2-Carboxamide / 1,3-Diisopropylcarbodiimide / 1-(3-Dimethylaminopropyl)-3-Ethylcarbodiimide Hydrochloride / 5-Amino-2-Benzimidazolinone
Shandong, China
Send Email
Sending...
Thank You！
Your requirement has been sent, we will contact you quickly!
Sent Failed！
Try again!
ABOUT US
Shandong jincheng pharmaceutical group co., LTD.(hereinafter referred to as "jincheng medicine", stock code: 300233) was established in 2004. It is a national high-tech enterprise and a listed enterprise on the gem. At present, the company owns Beijing jincheng strategy pharmaceutical technology co., LTD., Beijing lang in accordance with the pharmaceutical co., LTD., Shanghai jincheng pharmaceutical co., LTD., guangdong Jin Chengjin pharmaceutical co., LTD., shandong jincheng pharmaceutical chemical co., LTD., shandong jincheng biological pharmaceutical co., LTD., Italy haibao shows 23 GuCan holdings co., LTD., etc. Company through "enterprise + capital" two-wheel driven development model, building has formed unique characteristics of the jincheng medical health pharmaceutical industry chain, scope of business involving biopharmaceuticals, cephalosporin intermediates, characteristic, terminal dosage, health care products, new materials, new high-end medical equipment and other industries, and has been formed in the business income is 2.8 billion yuan, total assets of nearly 5 billion industry scale.
Company is three or four generation cephalosporin intermediates, API, biological pharmacy, terminal, and children's products for the main business of scientific research, production enterprises, including cephalosporins pharmaceutical intermediates product sales, sales income is the industry leader for many years, is an important biological pharmaceutical production base and domestic well-known medical health industry group. Leading products are glutathione (cyanine peptide), nitrate injunctions too capsule (lang), bisoprolol fumarate pesos capsule (jas), compound radix aucklandiae aluminum magnesium (driver), cefazolin sodium (AnSiFu ANCEF), AE - active ester, furan ammonium salt of nearly hundred kinds of.
Jincheng pharmaceutical has always taken innovation as the source power of enterprise development, and has always taken "continuously increasing investment in science and technology, promoting scientific and technological innovation and building scientific and technological competitiveness" as the central strategy of enterprise development. Company has taishan industry talents, a large number of academicians, Dr High-end talents of science and technology, focusing on research and development of cephalosporins pharmaceutical intermediates, polypeptide high-end biopharmaceuticals, biological pharmacy, anti-tumor, cardiovascular, gynecology, pediatrics, anti-infection, and other fields, in cephalosporin antibiotics production process of continuous research and development and technology applications of synthetic biology has accumulated rich experience in research and development and technology lead, animating the whole industry has promoted the technical level and rapid development. Company as the national torch program, the shandong province science and technology research project implementation unit, academician workstation, post-doctoral mobile workstations, enterprise technology centers recognized by the state, enterprise technology center in shandong province, shandong cephalosporin intermediates for engineering technology research center, has been authorized 88 national patents, in addition, hundreds of patents pending applications. In recent years, the company has won the "national science and technology progress prize", "the top 100 most respectable investors of listed companies", "best gem companies", "the most innovative of the listed company", "top 50 Chinese pharmaceutical industry growth", etc.
Basic Information
Tax ID
91370000164238285E
Country/Region
Shandong, China
Year Established
2004
Registered Capital
CNY 390.3 Million
Business Type
CRO
Total Employees
Over 1000 people
Quality Management Certificate
-
Total Annual Revenue
CNY 2692 Million
Enterprise Ownership
Private Owned
Is This Your Own Factory
Yes
Summary Up
It is an important biopharmaceutical production base and a well-known pharmaceutical and health industry group in China
PLANT LOCATION
COMPANY ALBUM
